Business ❯ Finance ❯ Mergers and Acquisitions

Pharmaceuticals

Oncology Eli Lilly Obesity Drugs Sun Pharma Alkermes and Avadel Pharmaceuticals Generic Drugs AstraZeneca Sun Pharmaceutical Industries Drug Development Life Sciences

3 ARTICLES

2w ago

AbbVie Completes $10.9 Billion Buy of Apogee Therapeutics

The company says it will use its global development and commercial reach to advance Apogee’s antibody programs targeting IL-13 and a combo that blocks TSLP.

8 ARTICLES

3w ago

Gilead to Buy Ouro Medicines for $1.675 Billion Upfront to Advance Autoimmune T‑Cell Engager

Pharmaceuticals

AbbVie Completes $10.9 Billion Buy of Apogee Therapeutics

Lilly to Buy Merida Biosciences for Up to $2.875 Billion

Reuters Says There Were No AstraZeneca‑Bristol Myers Merger Talks

AstraZeneca in Talks With Bristol Myers on Potential $400 Billion Merger

Eli Lilly Agrees to Buy Psychedelic Biotech AtaiBeckley for $2.8 Billion

Vertex to Buy Crinetics for $10 Billion, Gaining Oral Endocrine Drugs

Zymeworks to Buy Theravance for $929 Million

Merck to Buy Bio‑Techne for $11.3 Billion

AbbVie Agrees to Buy Apogee Therapeutics for $10.9 Billion

FTC Clears Aurobindo's $250 Million Purchase of Lannett

Never miss stories about

Pharmaceuticals

GSK to Buy Nuvalent for $10.6 Billion to Bolster Lung‑Cancer Pipeline

Zydus to Buy Assertio for $166.4 Million in All-Cash Deal

Angelini Pharma to Acquire Catalyst Pharmaceuticals for $4.1 Billion in Cash

Sun Pharma to Buy Organon for $11.75 Billion in All-Cash Deal

Ligand to Buy XOMA Royalty for $739 Million

Reports of Sun Pharma’s $12 Billion Organon Bid Jolt Stocks

Biogen to Buy Apellis for $5.6 Billion in Cash, Adding Syfovre and Empaveli

Lilly to Acquire Centessa for $6.3 Billion to Add Orexin Sleep Drugs

Merck to Acquire Terns for $6.7 Billion to Add Promising Leukemia Drug

Gilead to Buy Ouro Medicines for $1.675 Billion Upfront to Advance Autoimmune T‑Cell Engager

Never miss stories about

Pharmaceuticals